Article
CNVs conferring risk of autism or schizophrenia affect cognition in controls.
Nature - 16 Jan 2014
Stefansson Hreinn, Meyer-Lindenberg Andreas, Steinberg Stacy, Magnusdottir Brynja, Morgen Katrin, Arnarsdottir Sunna, Bjornsdottir Gyda, Walters G Bragi, Jonsdottir Gudrun A, Doyle Orla M, Tost Heike, Grimm Oliver, Kristjansdottir Solveig, Snorrason Heimir, Davidsdottir Solveig R, Gudmundsson Larus J, Jonsson Gudbjorn F, Stefansdottir Berglind, Helgadottir Isafold, Haraldsson Magnus, Jonsdottir Birna, Thygesen Johan H, Schwarz Adam J, Didriksen Michael, Stensbøl Tine B, Brammer Michael, Kapur Shitij, Halldorsson Jonas G, Hreidarsson Stefan, Saemundsen Evald, Sigurdsson Engilbert, Stefansson Kari
Abstract excerpt
In a small fraction of patients with schizophrenia or autism, alleles of copy-number variants (CNVs) in their genomes are probably the strongest factors contributing to the pathogenesis of the disease. These CNVs may provide an entry point for investigations into the mechanisms of brain function and dysfunction alike. They are not fully penetrant and offer an opportunity to study their effects separate from that...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
